Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study

@article{Nasr2009EffectsOT,
  title={Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study},
  author={Issam Nasr and Satish S C Rao and Ashok Attaluri and Syed Aizaz Ali Hashmi and Robert W. Summers},
  journal={Indian Journal of Gastroenterology},
  year={2009},
  volume={28},
  pages={136-142}
}
ObjectivesTegaserod may enhance upper gut transit, but, its prokinetic effects on antral/small bowel motility and how this compares with erythromycin is unknown. We prospectively assessed and compared the effects of tegaserod and erythromycin on upper gut motility.MethodsIn an open label, non-crossover study, 22 patients (M/F=4/18; mean age=37 years) with symptoms of upper gut dysmotility underwent 24-hour ambulatory antroduodenojejunal manometry with a six-sensor solid state probe. The effects… CONTINUE READING
BETA

Figures, Tables, and Topics from this paper.

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-3 OF 3 CITATIONS

Intestinal manometry: who needs it?

  • Gastroenterology and hepatology from bed to bench
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

Upper gastrointestinal promotility drugs: not all uniform?

  • Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology
  • 2009

References

Publications referenced by this paper.
SHOWING 1-10 OF 30 REFERENCES

Basic and clinical pharmacology of new motility promoting agents.

  • Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
  • 2005
VIEW 2 EXCERPTS

Effect of tegaserod on gut transit in male and female subjects.

  • Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
  • 2005
VIEW 1 EXCERPT

Pathophysiology of functional dyspepsia.

  • Best practice & research. Clinical gastroenterology
  • 2004
VIEW 1 EXCERPT